Ching W. Jaw

Former Principal Financial Officer((7))atCytokinetics· In proxies 2021–2024

Pay in FY2024-44% from the year before · Cytokinetics stock -43.7% the same year

Ching W. Jaw was paid $1.7M in FY2024 (Dec), down 44%. Cytokinetics stock fell 43.7% that year.

Pay$100 in the stock at the end of FY20 → $226

Pay is from the Summary Compensation Table of each Cytokinetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

CYTK
CytokineticsPublic company · 5 yr
- Former Principal Financial Officer((7))2021 – Present · 5 yrStock in role +193%

Roles come from the proxy statements of each company.

Activity

Pay
Cytokinetics Former CFO pay fell 44% to $1.7M. The stock fell 44% in FY2024 (Dec).
DEF 14AApr 10, 2025
Pay
Cytokinetics Former CFO pay rose 13% to $2.6M. The stock rose 1% in FY2022 (Dec).
DEF 14AApr 10, 2025
Pay
Cytokinetics Former CFO pay rose 14% to $3.0M. The stock rose 82% in FY2023 (Dec).
DEF 14AApr 8, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?